Olema (OLMA) director Graham Walmsley awarded 29,500 stock options at $9.51

Rhea-AI Filing Summary

Olema Pharmaceuticals director Graham G. Walmsley received a new stock option grant for 29,500 shares of common stock. The option has an exercise price of $9.51 per share and expires on June 18, 2036. The award vests in 12 equal monthly installments starting June 18, 2026, with any remaining unvested portion vesting in full on the date of Olema’s next annual stockholder meeting, in each case contingent on his continued service. Following this grant, Walmsley holds 29,500 stock options directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Graham G. Walmsley

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	29,500	$0.00	--

Holdings After Transaction: Stock Option (right to buy) — 29,500 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Stock options granted: 29,500 options Exercise price: $9.51 per share Expiration date: June 18, 2036 +3 more

6 metrics

Stock options granted 29,500 options Grant to director Graham G. Walmsley

Exercise price $9.51 per share Stock option strike price for Olema common stock

Expiration date June 18, 2036 Option term end date

Vesting schedule 12 monthly installments Equal installments starting June 18, 2026

Post-transaction options held 29,500 options Total options held directly after grant

Underlying shares 29,500 common shares Underlying Olema common stock for the option

Key Terms

Stock Option (right to buy), Grant, award, or other acquisition, Common Stock, vest, +1 more

5 terms

Stock Option (right to buy) financial

"security_title: "Stock Option (right to buy)""

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Common Stock financial

"underlying_security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

vest financial

"The shares subject to the option vest in a series of 12 successive equal monthly installments"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

annual meeting of stockholders financial

"Such shares vest in full on the date of the Issuer's next annual meeting of stockholders"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/23/2026 - 05:22 PM Accepted by SEC EDGAR 06/23/2026 - 05:21 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Graham G. Walmsley

(Last) (First) (Middle)

C/O LOGOS GLOBAL MANAGEMENT LP

1 LETTERMAN DRIVE, BLDG. C, STE C3-350

(Street)

SAN FRANCISCO CALIFORNIA 94129

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Olema Pharmaceuticals, Inc. [ OLMA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$9.51	06/18/2026		A		29,500		(1)	06/18/2036	Common Stock	29,500	$0	29,500	D

Explanation of Responses:

1. The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 18, 2026, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.

	/s/ Shawnte Mitchell, Attorney-in-Fact	06/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Olema Pharmaceuticals (OLMA) director Graham G. Walmsley report in this Form 4?

He reported receiving a stock option grant for 29,500 shares. The options relate to Olema common stock, are held directly, and were awarded as compensation rather than purchased in the open market, with vesting tied to his ongoing service on the board.

What are the key terms of Graham G. Walmsley’s new Olema (OLMA) stock options?

The grant covers 29,500 options at a $9.51 exercise price. The options expire on June 18, 2036 and give him the right to buy Olema common shares at that fixed price if vesting and service conditions are satisfied over time.

How do the Olema (OLMA) stock options granted to Graham G. Walmsley vest?

The options vest over 12 equal monthly installments from June 18, 2026. Any remaining unvested portion vests fully on the date of Olema’s next annual stockholder meeting, provided Walmsley continues serving through each applicable vesting date.

Did Graham G. Walmsley buy or sell Olema (OLMA) shares in the market in this Form 4?

No, the filing shows a compensation-related stock option grant, not a market trade. The transaction is coded “A” for grant, award, or other acquisition, with no reported open-market purchases or sales of Olema common stock.

How many Olema (OLMA) stock options does Graham G. Walmsley hold after this grant?

After the reported grant, he holds 29,500 stock options directly. The Form 4 shows this as his total option position following the transaction, with no additional remaining derivative positions listed in the derivative holdings summary.

What is the expiration date of Graham G. Walmsley’s Olema (OLMA) stock option grant?

The options expire on June 18, 2036. If any portion of the grant is unexercised by that date, the right to purchase Olema common stock at the $9.51 exercise price will lapse according to the Form 4 disclosure.